{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-011561","form_type":"8-K","ticker":"FBIO","cik":"0001429260","company_name":"Fortress Biotech, Inc.","filed_at":"2025-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.971619+00:00","generated_at":"2026-05-17T13:03:03.943271+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Fortress Biotech posts Q2 net income $13.4M; Checkpoint acquisition yields $28M upfront","bullets":["Checkpoint acquired by Sun Pharma in May; Fortress received ~$28M at close, up to $4.8M CVR, plus 2.5% royalty on UNLOXCYT sales.","FDA accepted CUTX-101 NDA for priority review; PDUFA goal date September 30, 2025.","Q2 consolidated net revenue $16.4M ($15.0M from dermatology); net income $13.4M vs net loss $13.3M a year ago.","Consolidated cash $74.4M as of June 30, up from $57.3M at Dec 31, 2024, boosted by Checkpoint proceeds.","Emrosi commercial launch underway; payer coverage expanded to 100M U.S. commercial lives as of July 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-011561","json":"https://secwatch.observer/filing/0001558370-25-011561.json","markdown":"https://secwatch.observer/filing/0001558370-25-011561.md","text":"https://secwatch.observer/filing/0001558370-25-011561.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1429260/000155837025011561/0001558370-25-011561-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1429260/000155837025011561/fbio-20250814x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T13:03:03.943271+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}